Technology appraisal decisions
NICE produces guidance on a wide range of drugs and other technologies to support the cost-effective use of NHS resources. This is an overview of the technology appraisal (TA) recommendations made by NICE and a table showing the classification of every appraisal recommendation.
During a technology appraisal, an independent committee (the Appraisal Committee) examines the evidence and reaches a consensus on the effectiveness and cost-effectiveness of a drug or technology. The committee uses information from clinical trials as well as information from patients and clinical experts. The committee then makes recommendations about the use of the drug or technology in the NHS. An appraisal may contain multiple technologies and therefore a number of recommendations may be made in each appraisal.
TA recommendation categories
NICE classifies each decision into one of four categories:
- only in research
- not recommended.
Table of all TA recommendations
All our TA recommendations are in our full table of TA recommendations.
Summary information about TA recommendations
We provide a summary of statistical information about our TA recommendations including how many technology appraisals we have published, of what type and how many recommendations we have made.
Questions answered about TA recommendations
- See the frequently asked questions about TA recommendations.
This page was last updated: 10 February 2014